Hypofractionated stereotactic radiation therapy: An effective therapy for recurrent high-grade gliomas

Journal of Clinical Oncology

Volumn 28, Issue 18, 2010, Pages 3048-3053

  Fogh, Shannon E ^a   Andrews, David W ^a   Glass, Jon ^a   Curran, Walter ^a   Glass, Charles ^a   Champ, Colin ^a   Evans, James J ^a   Hyslop, Terry ^a   Pequignot, Edward ^a   Downes, Beverly ^a   Comber, Eileen ^a   Maltenfort, Mitchell ^a   Dicker, Adam P ^a   Werner Wasik, Maria ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

BEVACIZUMAB; BORTEZOMIB; CARBOPLATIN; EPOTHILONE A; IRINOTECAN; SORAFENIB; SUNITINIB; TEMOZOLOMIDE; VINCRISTINE; ANTINEOPLASTIC AGENT;

ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER GRADING; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SURVIVAL; CRANIOTOMY; FEMALE; GLIOBLASTOMA; HEADACHE; HUMAN; HYPOFRACTIONATED STEREOTACTIC RADIOTHERAPY; MAJOR CLINICAL STUDY; MALE; NEUROTOXICITY; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGNOSIS; PROGRESSION FREE SURVIVAL; RADIATION DOSE; STEREOTACTIC TREATMENT; TREATMENT RESPONSE; TUMOR VOLUME; ADOLESCENT; ASTROCYTOMA; BRAIN TUMOR; CHILD; CLINICAL TRIAL; COHORT ANALYSIS; FOLLOW UP; MIDDLE AGED; MULTIMODALITY CANCER THERAPY; RADIATION DOSE FRACTIONATION; RADIOSURGERY; RETROSPECTIVE STUDY; STEREOTACTIC PROCEDURE; SURVIVAL RATE; TUMOR RECURRENCE;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; ASTROCYTOMA; BRAIN NEOPLASMS; CHILD; COHORT STUDIES; COMBINED MODALITY THERAPY; CRANIOTOMY; DOSE FRACTIONATION; FEMALE; FOLLOW-UP STUDIES; GLIOBLASTOMA; HUMANS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PROGNOSIS; RADIOSURGERY; RETROSPECTIVE STUDIES; STEREOTAXIC TECHNIQUES; SURVIVAL RATE; YOUNG ADULT;

EID: 77954600194     PISSN: 0732183X     EISSN: 15277755     Source Type: Journal    
DOI: 10.1200/JCO.2009.25.6941     Document Type: Article

References (39)

1. Jemal A, Siegel R, Ward E, et al: Cancer statistics, 2006. CA Cancer J Clin 56:106-130, 2006
2. Stupp R, Mason WP, van den Bent MJ, et al: Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 352:987-996, 2005 (Pubitemid 40349501)
3. Curran WJ Jr, Scott CB, Horton J, et al: Recursive partitioning analysis of prognostic factors in three Radiation Therapy Oncology Group malignant glioma trials. J Natl Cancer Inst 85:704-710, 1993 (Pubitemid 23133591)
4. Wallner KE, Galicich JH, Krol G, et al: Patterns of failure following treatment for glioblastoma multiforme and anaplastic astrocytoma. Int J Radiat Oncol Biol Phys 16:1405-1409, 1989 (Pubitemid 19154322)
5. Bernstein M, Laperriere N, Glen J, et al: Brachytherapy for recurrent malignant astrocytoma. Int J Radiat Oncol Biol Phys 30:1213-1217, 1994 (Pubitemid 24362535)
6. Chamberlain MC, Barba D, Kormanik P, et al: Stereotactic radiosurgery for recurrent gliomas. Cancer 74:1342-1347, 1994 (Pubitemid 24301790)
7. Gutin PH, Prados MD, Phillips TL, et al: External irradiation followed by an interstitial high activity iodine-125 implant "boost" in the initial treatment of malignant gliomas: NCOG study 6G-82-2. Int J Radiat Oncol Biol Phys 21:601-606, 1991
8. Hall WA, Djalilian HR, Sperduto PW, et al: Stereotactic radiosurgery for recurrent malignant gliomas. J Clin Oncol 13:1642-1648, 1995
9. Leibel SA, Gutin PH, Wara WM, et al: Survival and quality of life after interstitial implantation of removable high-activity iodine-125 sources for the treatment of patients with recurrent malignant gliomas. Int J Radiat Oncol Biol Phys 17:1129-1139, 1989 (Pubitemid 20028628)
10. Mehta MP, Masciopinto J, Rozental J, et al: Stereotactic radiosurgery for glioblastoma multiforme: Report of a prospective study evaluating prognostic factors and analyzing long-term survival advantage. Int J Radiat Oncol Biol Phys 30:541-549, 1994 (Pubitemid 24304464)
11. Scharfen CO, Sneed PK, Wara WM, et al: High activity iodine-125 interstitial implant for gliomas. Int J Radiat Oncol Biol Phys 24:583-591, 1992
12. Shrieve DC, Alexander E 3rd, Wen PY, et al: Comparison of stereotactic radiosurgery and brachytherapy in the treatment of recurrent glioblastoma multiforme. Neurosurgery 36:275-282, 1995; discussion 282-284
13. Corn BW, Curran WJ Jr, Shrieve DC, et al: Stereotactic radiosurgery and radiotherapy: New developments and new directions. Semin Oncol 24:707-714, 1997
14. Macdonald DR, Cascino TL, Schold SC Jr, et al: Response criteria for phase II studies of supratentorial malignant glioma. J Clin Oncol 8:1277-1280, 1990 (Pubitemid 20195640)
15. Gill SS, Thomas DG, Warrington AP, et al: Relocatable frame for stereotactic external beam radiotherapy. Int J Radiat Oncol Biol Phys 20:599-603, 1991
16. Carson KA, Grossman SA, Fisher JD, et al: Prognostic factors for survival in adult patients with recurrent glioma enrolled onto the new approaches to brain tumor therapy CNS consortium phase I and II clinical trials. J Clin Oncol 25:2601-2606, 2007 (Pubitemid 47041234)
17. Wong ET, Hess KR, Gleason MJ, et al: Outcomes and prognostic factors in recurrent glioma patients enrolled onto phase II clinical trials. J Clin Oncol 17:2572-2578, 1999 (Pubitemid 29368260)
18. Vredenburgh JJ, Desjardins A, Herndon JE 2nd, et al: Bevacizumab plus irinotecan in recurrent glioblastoma multiforme. J Clin Oncol 25:4722-4729, 2007 (Pubitemid 350086473)
19. Combs SE, Thilmann C, Edler L, et al: Efficacy of fractionated stereotactic reirradiation in recurrent gliomas: Long-term results in 172 patients treated in a single institution. J Clin Oncol 23:8863-8869, 2005 (Pubitemid 46211533)
20. Combs SE, Gutwein S, Schulz-Ertner D, et al: Temozolomide combined with irradiation as post-operative treatment of primary glioblastoma multiforme: Phase I/II study. Strahlenther Onkol 181:372-377, 2005 (Pubitemid 40875261)
21. Lederman G, Wronski M, Arbit E, et al: Treatment of recurrent glioblastoma multiforme using fractionated stereotactic radiosurgery and concurrent paclitaxel. Am J Clin Oncol 23:155-159, 2000
22. Arcicasa M, Roncadin M, Bidoli E, et al: Reirradiation and lomustine in patients with relapsed high-grade gliomas. Int J Radiat Oncol Biol Phys 43:789-793, 1999 (Pubitemid 29152651)
23. Glass J, Silverman CL, Axelrod R, et al: Fractionated stereotactic radiotherapy with cis-platinum radiosensitization in the treatment of recurrent, progressive, or persistent malignant astrocytoma. Am J Clin Oncol 20:226-229, 1997 (Pubitemid 27221038)
24. Combs SE, Bischof M, Welzel T, et al: Radiochemotherapy with temozolomide as reirradiation using high precision fractionated stereotactic radiotherapy (FSRT) in patients with recurrent gliomas. J Neurooncol 89:205-210, 2008
25. Larson DA, Prados M, Lamborn KR, et al: Phase II study of high central dose Gamma Knife radiosurgery and marimastat in patients with recurrent malignant glioma. Int J Radiat Oncol Biol Phys 54:1397-1404, 2002 (Pubitemid 35380040)
26. Schäfer U, Micke O, Schuller P, et al: The effect of sequential radiochemotherapy in preirradiated malignant gliomas in a phase II study. J Neurooncol 67:233-239, 2004 (Pubitemid 38418274)
27. Schönekaes K, Mucke R, Panke J, et al: Combined radiotherapy and temozolomide in patients with recurrent high grade glioma. Tumori 88:28-31, 2002 (Pubitemid 34269795)
28. VanderSpek L, Fisher B, Bauman G, et al: 3D conformal radiotherapy and cisplatin for recurrent malignant glioma. Can J Neurol Sci 35:57-64, 2008 (Pubitemid 351518289)
29. Hudes RS, Corn BW, Werner-Wasik M, et al: A phase I dose escalation study of hypofractionated stereotactic radiotherapy as salvage therapy for persistent or recurrent malignant glioma. Int J Radiat Oncol Biol Phys 43:293-298, 1999 (Pubitemid 29091467)
30. Shepherd SF, Laing RW, Cosgrove VP, et al: Hypofractionated stereotactic radiotherapy in the management of recurrent glioma. Int J Radiat Oncol Biol Phys 37:393-398, 1997 (Pubitemid 27138724)
31. Laing RW, Warrington AP, Graham J, et al: Efficacy and toxicity of fractionated stereotactic radiotherapy in the treatment of recurrent gliomas (phase I/II study). Radiother Oncol 27:22-29, 1993 (Pubitemid 23180137)
32. Florell RC, Macdonald DR, Irish WD, et al: Selection bias, survival, and brachytherapy for glioma. J Neurosurg 76:179-183, 1992
33. Lederman G, Arbit E, Odaimi M, et al: Fractionated stereotactic radiosurgery and concurrent taxol in recurrent glioblastoma multiforme: A preliminary report. Int J Radiat Oncol Biol Phys 40:661-666, 1998 (Pubitemid 28104237)
34. Alexander E 3rd, Loeffler JS: Radiosurgery using a modified linear accelerator. Neurosurg Clin N Am 3:167-190, 1992
35. Kim HK, Thornton AF, Greenberg HS, et al: Results of re-irradiation of primary intracranial neoplasms with three-dimensional conformal therapy. Am J Clin Oncol 20:358-363, 1997 (Pubitemid 27329567)
36. Cho KH, Hall WA, Gerbi BJ, et al: Single dose versus fractionated stereotactic radiotherapy for recurrent high-grade gliomas. Int J Radiat Oncol Biol Phys 45:1133-1141, 1999
37. Schwer AL, Damek DM, Kavanagh BD, et al: A phase I dose-escalation study of fractionated stereotactic radiosurgery in combination with gefitinib in patients with recurrent malignant gliomas. Int J Radiat Oncol Biol Phys 70:993-1001, 2008 (Pubitemid 351296121)
38. Grosu AL, Weber WA, Franz M, et al: Reirradiation of recurrent high-grade gliomas using amino acid PET (SPECT)/CT/MRI image fusion to determine gross tumor volume for stereotactic fractionated radiotherapy. Int J Radiat Oncol Biol Phys 63:511-519, 2005 (Pubitemid 41317169)
39. Mayer R, Sminia P: Reirradiation tolerance of the human brain. Int J Radiat Oncol Biol Phys 70:1350-1360, 2008 (Pubitemid 351417752)